Tech Company Financing Transactions

Evolutionary Genomics Funding Round

Private investors invested in a $436 thousand funding round for Evolutionary Genomics. The round was recorded on 9/30/2012.

Transaction Overview

Announced On
9/30/2012
Transaction Type
Venture Equity
Amount
$436,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
1026 Anaconda Dr.
Castle Rock, CO 80108
USA
Email Address
Overview
We have used the Adapted Traits Platform to find genes responsible for increased crop yield, pest and disease resistance, salt tolerance and even sweetness. We believe that we can apply this same technology to help develop seeds for drought resistance crops.
Profile
Evolutionary Genomics LinkedIn Company Profile
Social Media
Evolutionary Genomics Company Twitter Account
Company News
Evolutionary Genomics News
Facebook
Evolutionary Genomics on Facebook
YouTube
Evolutionary Genomics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Steve Warnecke
  Steve Warnecke LinkedIn Profile  Steve Warnecke Twitter Account  Steve Warnecke News  Steve Warnecke on Facebook
Chief Technical Officer
Walter Messier
  Walter Messier LinkedIn Profile  Walter Messier Twitter Account  Walter Messier News  Walter Messier on Facebook
Founder
Virginia Orndorff
  Virginia Orndorff LinkedIn Profile  Virginia Orndorff Twitter Account  Virginia Orndorff News  Virginia Orndorff on Facebook


 

 

Browse more venture capital transactions:

Prev: 9/30/2012: SiTime venture capital transaction
Next: 9/30/2012: Armune BioScience venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We report on funding rounds that are announced publicly. VC transactions reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary